
Cancer drug trial studies urged to report harms transparently
Many reports of cancer drug trials use general or subjective terms to describe harms, finds…
Many reports of cancer drug trials use general or subjective terms to describe harms, finds…
A trial to test an experimental drug in patients with head and neck cancer launches…
By Brigid O’Gorman. Researchers from Sydney’s Garvan Institute of Medical Research and the UK have developed a glow-in-the-dark…
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer…
In a new paradigm of breast cancer research, physicians are fast-tracking promising new experimental drugs…